620 A Study of PNT2258 (DNA-targeted Blocker of BCL2 Expression) in Patients with Advanced Solid Tumors

Autor: Rasco, D.W., Patnaik, A., Amaya, A., Gaylor, S., Moore, T., Izbicka, E., Streeper, R., Rodrigueza, W., Messmann, R., Tolcher, A.
Zdroj: In European Journal of Cancer November 2012 48 Supplement 6:191-191
Databáze: ScienceDirect